Sunday, August 6, 2023

Governance Startups: Incorporate values for better valuation

Governance Startups: Incorporate values for better valuation Risk and governance are two sides of the same coin. Yet both have remained confined to boardrooms and regulations rather than being absorbed as a part of corporate culture

from Moneycontrol Business News https://ift.tt/GysZEF2

Solara#39;s Cuddalore facility gets all clear from US FDA

Solara#39;s Cuddalore facility gets all clear from US FDA US FDA inspected the unit, which is a multi-product facility, and found it to be in an “acceptable state of compliance”, the company said

from Moneycontrol Business News https://ift.tt/1K0iVCe

Vijay Shekhar Sharma to purchase 10.3% stake in Paytm from Antfin

Vijay Shekhar Sharma to purchase 10.3% stake in Paytm from Antfin An overseas entity owned by Sharma will acquire 10.3 percent stake in Paytm from Antfin through an off-market transfer. On closing of this transaction, Sharma’s shareholding in Paytm will increase to 19.42 percent, whereas Antfin’s shareholding will reduce to 13.5 percent

from Moneycontrol Business News https://ift.tt/95IcEzL

A sin tax on online gaming allows the government to sidestep the morality debate

A sin tax on online gaming allows the government to sidestep the morality debate Gaming and casinos have joined crypto trading, cigarettes and liquor in the category of activities which fall under the dreaded sin tax bracket in India. But do sin taxes work, and how?

from Moneycontrol Business News https://ift.tt/Xo5GO8L

Saturday, August 5, 2023

ITC Hotels could list in nine months, board meet on August 14

ITC Hotels could list in nine months, board meet on August 14 The conglomerate cited an intimation to the stock exchanges from July 24 that states that the scheme of arrangement shall be placed for approval of the board at its next meeting to be convened on August 14.

from Moneycontrol Business News https://ift.tt/XKqs8Yz

ITC Hotels could list in nine months, board meet on August 14

ITC Hotels could list in nine months, board meet on August 14 The conglomerate cited an intimation to the stock exchanges from July 24 that states that the scheme of arrangement shall be placed for approval of the board at its next meeting to be convened on August 14.

from Moneycontrol Business News https://ift.tt/FB6uDPJ

Friday, August 4, 2023

Cipla#39;s impending #39;takeover#39; by Blackstone should sadden all of us: Jairam Ramesh

Cipla#39;s impending #39;takeover#39; by Blackstone should sadden all of us: Jairam Ramesh The Congress general secretary shared a media report on Twitter which claimed that Blackstone, the world#39;s largest private equity fund, is set to submit a non-binding bid as early as next week to acquire the entire 33.47 per cent promoter stake in Cipla.

from Moneycontrol Business News https://ift.tt/DSUFAMK

Thursday, August 3, 2023

Apple, Amazon beat forecast numbers. Here are the top highlights

Apple, Amazon beat forecast numbers. Here are the top highlights Silicon Valley tech giants Apple and Amazon bettered markets expectations with their earnings reports on August 3.

from Moneycontrol Business News https://ift.tt/qi3zPIc

Tesla discusses India plans with commerce minister Piyush Goyal in Delhi: Report

Tesla discusses India plans with commerce minister Piyush Goyal in Delhi: Report Tesla has expressed an interest in building a factory in India that would produce a low-cost electric vehicle (EV) priced at $24,000, around 25% cheaper than Tesla#39;s current entry model, for both the Indian market and export.

from Moneycontrol Business News https://ift.tt/kAqGoUP

KKR in advanced talks to buy Simon Schuster for $1.65 billion: Report

KKR in advanced talks to buy Simon Schuster for $1.65 billion: Report KKR was competing against bidders including News Corp-owned HarperCollins Publishers for Simon Schuster and investor Richard Hurowitz, the sources said.

from Moneycontrol Business News https://ift.tt/syvjZAC

Zydus Lifesciences gets USFDA nod for generic rheumatoid arthritis treatment drug

Zydus Lifesciences gets USFDA nod for generic rheumatoid arthritis treatment drug The approval by the US Food and Drug Administration (USFDA) is for manufacturing and marketing of Indomethacin suppositories of 50mg strength, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/WcZFG2d

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...